Drug Information Association Logo

Regulatory Affairs for Biologics

« Back to Listing

Overview 

Participants in this training course will learn the differences between traditional biologics and biotechnology products, the regulatory needs and requirements for biologics, the unique aspects in the development of specific biologics such as vaccines and cellular therapy, and the different ways that CBER and CDER view product development. The course will also discuss proven strategies to achieve regulatory success in the development of biologics.
« Back to Listing Back To Top